Peptide Series I: Understand Recovery and Inflammation Research

Interest in peptides for recovery and inflammation is growing, but the evidence varies considerably by substance. In the first session of this three-part series, we’ll examine BPC-157, TB-500, and KPV: how they are proposed to work, what has been studied, and where important questions remain.

You’ll hear how to distinguish findings from animal and laboratory studies from human evidence, review safety and dosing limitations discussed in the presentation, and gain context for evaluating claims you may encounter in practice.

This webinar is designed for:

• Functional and integrative medicine providers following peptide research
• Sports medicine clinicians interested in recovery-related evidence
• Providers who want clarity on emerging research and its limitations
• Prescribers seeking context for patient questions about these peptides

You’ll learn how to:

• Explain the proposed mechanisms of BPC-157, TB-500, and KPV
• Distinguish peptide-specific findings from research on related molecules
• Assess where preclinical evidence ends and human evidence is limited
• Recognize key safety, dosing, and regulatory considerations raised in the session